Entity Details
| Primary name |
UBP27_HUMAN |
| Entity type |
UniProt |
| Source |
Source Link |
Details
| Accession | A6NNY8 |
| EntryName | UBP27_HUMAN |
| FullName | Ubiquitin carboxyl-terminal hydrolase 27 |
| TaxID | 9606 |
| Evidence | evidence at transcript level |
| Length | 438 |
| SequenceStatus | complete |
| DateCreated | 2007-10-02 |
| DateModified | 2021-06-02 |
Subcellular Location
Show/Hide Table
| Subcellular Location |
| Cytoplasm |
| Nucleus |
Domains
Show/Hide Table
| Domain | Name | Category | Type |
| IPR001394 | Peptidase C19, ubiquitin carboxyl-terminal hydrolase | Domain | Domain |
| IPR018200 | Ubiquitin specific protease, conserved site | Site | Conserved site |
| IPR028889 | Ubiquitin specific protease domain | Domain | Domain |
| IPR038765 | Papain-like cysteine peptidase superfamily | Family | Homologous superfamily |
Diseases
Show/Hide Table
| Disease ID | Source | Name | Description |
| 300984 | OMIM | Mental retardation, X-linked 105 (MRX105) | A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. The disease is caused by variants affecting the gene represented in this entry. |
Interactions
4 interactions